Company / Total Assets
ORAMED PHARMACEUTICALS INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$230.9M
FY2025
5-year range
$128.0M / $230.9M
FY2021-FY2025
Trend
+48.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $35M in FY2019 to $231M in FY2025.
Based on SEC 10-K filings.
$231M in FY2025 with a 5-year CAGR of +38.9%.
Improved from $221M to $231M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.6%
- 5-Year CAGR
- +38.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +38.9%, indicating consistent growth.
- In FY2025, total assets increased 48.7% year-over-year.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $230.9M | +48.7% |
| FY2024 | $155.3M | -29.6% |
| FY2023 | $220.6M | +36.4% |
| FY2022 | $161.6M | +26.3% |
| FY2021 | $128.0M | +186.8% |
| FY2020 | $44.6M | +28.8% |
| FY2019 | $34.7M | -26.9% |
| FY2018 | $47.4M | +22.4% |
| FY2017 | $38.7M | -9.6% |
| FY2016 | $42.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026